NAE modulators: A potential therapy for gastric carcinoma

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Neural precursor cell expressed developmentally downregulated protein-8 (NEDD8) is a ubiquitin-like protein crucial for neddylation, a post-translational modification impacting protein stability.
• Aberrant NEDD8 activity is linked to various cancers, including gastric carcinoma.
• NEDD8 activating enzyme (NAE) initiates the NEDD8 cascade and is a significant target for anti-tumor drug development.

Purpose of the Study:

• To elucidate the structural characteristics, catalytic sites, and mechanism of NAE.
• To explore the relationship between neddylation and tumors via NAE's regulation of downstream pathways.
• To review recent NAE modulators, focusing on their discovery, structure-activity relationships, efficacy, mechanisms, and clinical research.

Main Methods:

• Literature review of NAE structure, function, and modulators.
• Analysis of neddylation's role in tumorigenesis, particularly gastric carcinoma.
• Evaluation of NAE inhibitors and agonists for anti-cancer potential.

Main Results:

• NAE's structure, catalytic site, and mechanism are detailed.
• The link between neddylation, NAE activity, and cancer development is established.
• Various NAE modulators demonstrate anti-tumor efficacy, with expanding applications beyond hematological malignancies.

Conclusions:

• NAE modulators are promising therapeutic agents for solid tumors, especially gastric carcinoma.
• Further research into NAE modulator development is warranted to address existing challenges and explore new directions.
• Understanding NAE's role in cancer provides a basis for targeted anti-tumor drug discovery.